Klp Kapitalforvaltning As Day One Biopharmaceuticals, Inc. Transaction History
Klp Kapitalforvaltning As
- $20.6 Billion
- Q4 2024
A detailed history of Klp Kapitalforvaltning As transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 11,800 shares of DAWN stock, worth $140,656. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,800Holding current value
$140,656% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DAWN
# of Institutions
183Shares Held
82.7MCall Options Held
148KPut Options Held
218K-
Ra Capital Management, L.P. Boston, MA7.87MShares$93.8 Million1.53% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$76.6 Million13.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.85MShares$69.7 Million0.0% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$58.1 Million1.92% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$54 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $876M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...